Rho Kinases in Cardiovascular Physiology and Pathophysiology
Top Cited Papers
- 17 February 2006
- journal article
- review article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 98 (3) , 322-334
- https://doi.org/10.1161/01.res.0000201960.04223.3c
Abstract
Rho kinases (ROCKs) are the first and the best-characterized effectors of the small G-protein RhoA. In addition to their effect on actin organization, or through this effect, ROCKs have been found to regulate a wide range of fundamental cell functions such as contraction, motility, proliferation, and apoptosis. Abnormal activation of the RhoA/ROCK pathway has been observed in major cardiovascular disorders such as atherosclerosis, restenosis, hypertension, pulmonary hypertension, and cardiac hypertrophy. This review, based on recent molecular, cellular, and animal studies, focuses on the current understanding of ROCK signaling and its roles in cardiovascular physiology and pathophysiology.Keywords
This publication has 110 references indexed in Scilit:
- Rho/Rho-Kinase Pathway Contributes to C-Reactive Protein–Induced Plasminogen Activator Inhibitor-1 Expression in Endothelial CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Direct cleavage of ROCK II by granzyme B induces target cell membrane blebbing in a caspase-independent mannerThe Journal of Experimental Medicine, 2005
- Rho-associated kinases play a role in endocardial cell differentiation and migrationDevelopmental Biology, 2004
- Interaction of Rho‐kinase with myosin II at stress fibresGenes to Cells, 2004
- Rho‐associated kinases play an essential role in cardiac morphogenesis and cardiomyocyte proliferationDevelopmental Dynamics, 2002
- Sphingosylphosphorylcholine Is a Novel Messenger for Rho-Kinase–Mediated Ca 2+ Sensitization in the Bovine Cerebral ArteryCirculation Research, 2002
- Rho/ROCK Pathway Contributes to the Activation of Extracellular Signal-regulated Kinase/GATA-4 during Myocardial Cell HypertrophyJournal of Biological Chemistry, 2002
- Identification of Calponin as a Novel Substrate of Rho-KinaseBiochemical and Biophysical Research Communications, 2000
- Agonists Trigger G Protein-mediated Activation of the CPI-17 Inhibitor Phosphoprotein of Myosin Light Chain Phosphatase to Enhance Vascular Smooth Muscle ContractilityJournal of Biological Chemistry, 2000
- The Kinase Inhibitor Fasudil (HA-1077) Reduces Intimal Hyperplasia through Inhibiting Migration and Enhancing Cell Loss of Vascular Smooth Muscle CellsBiochemical and Biophysical Research Communications, 1999